I agree that this site is using cookies. You can find further informations here.
X
Ouwerkerk-Mahadevan, Sivi
30  results:
Search for persons X
?
1

SAT-341 Discovery of a pan-genotypic hepatitis E virus repl..:

Zhang, Xin ; Klöhn, Mara ; Ouwerkerk-Mahadevan, Sivi...
Journal of Hepatology.  80 (2024)  - p. S732-S733 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Re..:

Kruger, Terra M. ; Valenzuela, Belén ; Thompson, Charles D...
Clinical Pharmacokinetics.  , 2023
Link: https://doi.org/10.1007/..
 
?
3

Effect of Ponesimod Exposure on Total Lymphocyte Dynamics i..:

Valenzuela, Belén ; Pérez-Ruixo, Juan-José ; Leirens, Quentin..
Clinical Pharmacokinetics.  60 (2021)  9 - p. 1239-1250 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Population Pharmacokinetics of AL-335 and Its Two Main Meta..:

Valade, Elodie ; Kakuda, Thomas N. ; McClure, Matthew W....
The AAPS Journal.  21 (2018)  1 - p. , 2018
Link: https://doi.org/10.1208/..
 
?
5

Characterizing the Pharmacokinetic Interaction Between Sime..:

Valade, Elodie ; Valenzuela, Belén ; Kakuda, Thomas N....
The AAPS Journal.  20 (2018)  6 - p. , 2018
Link: https://doi.org/10.1208/..
 
?
6

Population Pharmacokinetic Modeling of JNJ-53718678, a Nove..:

Huntjens, Dymphy R. H. ; Ouwerkerk-Mahadevan, Sivi ; Brochot, Anne...
Clinical Pharmacokinetics.  56 (2017)  11 - p. 1331-1342 , 2017
Link: https://doi.org/10.1007/..
 
?
7

Elucidating the Plasma and Liver Pharmacokinetics of Simepr..:

Snoeys, Jan ; Beumont, Maria ; Monshouwer, Mario.
Clinical Pharmacokinetics.  56 (2016)  7 - p. 781-792 , 2016
Link: https://doi.org/10.1007/..
 
?
8

Daclatasvir plus simeprevir with or without ribavirin for t..:

Zeuzem, Stefan ; Hézode, Christophe ; Bronowicki, Jean-Pierre...
Journal of Hepatology.  64 (2016)  2 - p. 292-300 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Efficacy and safety of simeprevir with PegIFN/ribavirin in ..:

Moreno, Christophe ; Hezode, Christophe ; Marcellin, Patrick...
Journal of Hepatology.  62 (2015)  5 - p. 1047-1055 , 2015
Link: https://doi.org/10.1016/..
 
?
10

Pharmacokinetics of bound and unbound telaprevir in cirrhot..:

Ouwerkerk-Mahadevan, Sivi ; Halabi, Atef ; Cieslarová, Blanka...
The Journal of Clinical Pharmacology.  55 (2015)  10 - p. 1147-1156 , 2015
Link: https://doi.org/10.1002/..
 
?
11

Evaluation of the Pharmacokinetics and Renal Excretion of S..:

Ouwerkerk-Mahadevan, Sivi ; Beumont-Mauviel, Maria ; Mortier, Steven...
Drugs in R&D.  15 (2015)  3 - p. 261-270 , 2015
Link: https://doi.org/10.1007/..
 
?
12

Drug–Drug Interactions with the NS3/4A Protease Inhibitor S..:

Ouwerkerk-Mahadevan, Sivi ; Snoeys, Jan ; Peeters, Monika..
Clinical Pharmacokinetics.  55 (2015)  2 - p. 197-208 , 2015
Link: https://doi.org/10.1007/..
 
?
13

Telaprevir-based therapy in patients coinfected with chroni..:

Montes, Maria Luisa ; Nelson, Mark ; Girard, Pierre-Marie...
Journal of Antimicrobial Chemotherapy.  71 (2015)  1 - p. 244-250 , 2015
Link: https://doi.org/10.1093/..
 
?
14

Simeprevir with pegylated interferon alfa 2a or 2b plus rib..:

Manns, Michael ; Marcellin, Patrick ; Poordad, Fred...
The Lancet.  384 (2014)  9941 - p. 414-426 , 2014
Link: https://doi.org/10.1016/..
 
?
15

Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in ..:

Dieterich, Douglas ; Rockstroh, Jürgen Kurt ; Orkin, Chloe...
Clinical Infectious Diseases.  59 (2014)  11 - p. 1579-1587 , 2014
Link: https://www.jstor.org/st..
 
1-15